USA – Residual Solvents in Drug Products Marketed in the United States

This guidance is intended to assist manufacturers in responding to the issuance of the United States Pharmacopeia (USP) requirement; for the control of residual solvents in drug products marketed in the United States. Specifically, this guidance makes recommendations on the following…